CONNECT WITH US:
Jun, 28 2018 07:00 JST
Novotech at DIA18 announces Asia Partnerships on Target to Reach 1.4 Bil Patients
BOSTON, Jun, 28 2018 - (ACN Newswire) - Asia-Pacific CRO Novotech announced at DIA18 (24-28 June, Boston Convention and Exhibition Center) that it has signed Memorandums of Understanding (MOUs) with five of the leading medical institutions in the region. The MOU partnership program is designed to give Novotech clients access to an additional 1.4 billion patients, and specialist investigators with advanced clinical research sites.
Novotech made the announcement at the DIA conference (Booth 1904).
Novotech Director of Business Development Barry Murphy who is attending the conference said: "Novotech has now signed five MOUs with medical institutions across the region with two more being signed in Thailand and the Philippines next month.
"Asia is the highest growth region for clinical research in the world, and as the Asia-Pacific CRO, we bring access to the key sites and KOLs to our clients via well-developed partnerships and relationships on the ground in Asia. Our MOUs further formalise these relationships.
"Some of the new MOUs are with the largest institutes in the region, such as the China Medical University Hospital in Taiwan which has more than a 2,000-bed facilities with dedicated clinical trials centres."
The partnerships are designed to give Novotech clients:
- Faster start-up times
- Access to significant patient database
- World-class clinical research - regulatory compliance with FDA, PMDA and EMEA
- Outstanding recruiters across many therapeutic areas: breast cancer, lung cancer, colorectal cancer, Hepatitis, SLE, RA, Stroke, Diabetes, etc.
- Leading principal investigators
The partnerships involve the provision of professional and medical clinical trial advice to the Novotech team including feasibility, principal investigator selection, and assistance with patient recruitment, while Novotech will promote the clinical research capabilities of these institutions internationally.
Novotech Executive Director, Asia Operations Dr. Yooni Kim said: "The partnerships mean Novotech has dedicated clinical experts within these leading hospital organisations to support and prioritise rapid clinical processes for Novotech biopharma clients.
"Novotech is the Asia-Pacific CRO, so is committed to establishing ongoing engagement with leading medical institutions in each country across the Asia-Pacific region. We have offices and teams on the ground as well as MOUs and long-term relationships with major hospitals that directly benefit our clients.
"Our in-country relationships enable a more comprehensive understanding of local regulatory changes, access to leading PIs, strong site connections, and productive patient populations to deliver success for our clients within timelines and budgets," Dr. Kim said.
Novotech is the Asia-Pacific specialist contract research organization (CRO) established in 1996, headquartered in Australia with offices in 11 countries across the region.
See the latest data on Asia clinical trials here:
About Novotech - www.novotech-cro.com
Headquartered in Sydney, Novotech is internationally recognised as the leading regional full-service contract research organisation (CRO). With a focus on clinical monitoring, Novotech has been instrumental in the success of hundreds of Phase I - IV clinical trials in the Asia Pacific region.
Novotech provides clinical development services across all clinical trial phases and therapeutic areas including: feasibility assessments; ethics committee and regulatory submissions, data management, statistical analysis, medical monitoring, safety services, central lab services, report write-up to ICH requirements, project and vendor management. Novotech's strong Asia Pacific presence includes running clinical trials in all key regional markets. Novotech also has worldwide reach through the company's network of strategic partners.
For RFP enquiries: see
Novotech DIA Contact
Director of Business Development
AU: +61 2 8218 2144
USA: +1 415 951 3228
ASIA: +65 3159 3427
Copyright ©2019 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.
Toyota Yaris WRC Set for Crucial Mixed-surface Spectacular
Oct 18, 2019 17:37 JST
Overview of Honda Exhibits at the 26th ITS World Congress 2019 in Singapore
Oct 18, 2019 15:46 JST
Hitachi Automotive Systems Starts Mass Production of High Voltage and High Output EV Inverter, the First in the World
Oct 18, 2019 15:33 JST
Hitachi Launches Dashboard for Building Owners and Managers to Check the Operation and Maintenance Status of Building Facilities, Including Elevators
Oct 18, 2019 09:03 JST
Toyota to Show Production-Ready Ultra-Compact BEV at 2019 Tokyo Motor Show "FUTURE EXPO"
Oct 17, 2019 13:48 JST
Monumental Sports & Entertainment, NEC Announce Partnership with Washington Wizards
Oct 16, 2019 17:45 JST
NEC Announces First International Partnership with Professional Basketball Player Rui Hachimura
Oct 16, 2019 17:33 JST
Hitachi and Frasers Property Sign S$100 Million MOU to Drive Digital Transformation in the Real Estate Industry in Asia Pacific
Oct 16, 2019 16:02 JST
Toyota's New Model Yaris Makes World Premiere
Oct 16, 2019 15:32 JST
Ministry of Movement and NEC to Collaborate on Future of Urban Mobility
Oct 16, 2019 15:04 JST
Eisai's New Drug Approval for Fycompa for Adjunctive Treatment of Partial Onset Seizures in China
Oct 15, 2019 21:24 JST
Fujitsu's Gymnastics Judging Support System Wins the "Minister of Internal Affairs and Communications Award" at CEATEC 2019
Oct 15, 2019 16:25 JST
Fujitsu Develops AI based Facial Expression Recognition Technology to Accurately Detect Subtle Changes in Expression
Oct 15, 2019 16:09 JST
Toyota Rolls Out New Compact Convertible Sports Car "Copen GR SPORT" in Japan
Oct 15, 2019 14:09 JST
Mazda Publishes Mazda Sustainability Report 2019 and Annual Report 2019
Oct 15, 2019 13:27 JST
Mazda Included in Dow Jones Sustainability Asia Pacific Index for Third Year Running
Oct 15, 2019 13:16 JST
Toyota: 'People of the Future' to Welcome Visitors at 'Mobility Theme Park'
Oct 11, 2019 16:14 JST
Toyota to Unveil Next-Generation "Mirai Concept" at 2019 Tokyo Motor Show's "Future Expo"
Oct 11, 2019 13:45 JST
Hitachi Expands Its Elevators & Escalators Business in Laos
Oct 10, 2019 19:53 JST
MHIENG Completes First Delivery of 7000-Series New-Series Carriages for Hiroshima Rapid Transit's "Astram Line"
Oct 10, 2019 16:11 JST
More Latest Release >>
Novotech CRO partners Skin Research Institute of Singapore (SRIS) for Skin Disorder Research
July 11 2019 11:00 JST
Novotech Awarded Asia-Pacific Biotech CRO of the Year - Announced at ASCO
May 31 2019 07:00 JST
Novotech CRO strengthens South Korean Clinical Capabilities, partners with 2 Major Hospitals
April 18 2019 04:00 JST
Novotech CNS USA Appoints Dr Robert Malone to its Washington, DC BioDesk
March 25 2019 18:00 JST
Novotech CRO Launches Largest Oracle Trial Management and Monitoring Cloud Service Implementation in Asia-Pacific
December 17 2018 08:00 JST
Novotech CRO Announces 41 Clinical Staff and 81 Projects in South Korea
November 28 2018 11:02 JST
Novotech and CNS deal expands CRO services for Biopharma Clients across Asia-Pacific
October 19 2018 07:00 JST
Novotech the Asia-Pacific CRO named Top 10 CRO
August 23 2018 13:00 JST
Sponsors Recommend Novotech for CRO Leadership Award
August 09 2018 13:00 JST
Novotech Partners with Asian Eye Institute for Accelerated Ophthalmic Drug and Devices Clinical Trials
July 19 2018 06:00 JST
More Press release >>